The coronavirus (COVID-19) has spread through Germany between 2020 and 2024. As of April 2024, there were over 38.8 million cases recorded in the country. . Click here for more statistical data and facts on the coronavirus.

The coronavirus (COVID-19) has led to over 183,000 deaths in Germany, as of 2024. When looking at the distribution of deaths by age, based on the figures currently available, most death occurred in the age group 80 years and older at approximately 118,938 deaths.

As of November 24, 2024 there were over 274 million confirmed cases of coronavirus (COVID-19) across the whole of Europe since the first confirmed cases in France in January 2020. France has been the worst affected country in Europe with 39,028,437 confirmed cases, followed by Germany with 38,437,756 cases. Italy and the UK have approximately 26.8 million and 25 million cases respectively. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This report includes Analysis, market forecasts, brands, consumer attitudes and trends in the German Apparel Market 2019-2024 with COVID-19 impact Read More

Mouthwash (Oral Hygiene) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Mouthwash market in Germany. Read More

Sanitary Pads (Feminine Hygiene) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Sanitary Pads market in Germany. Read More

Passenger Airlines (Airlines whose primary business is the transport of passengers) market has evolved dramatically in the recent years. The report Germany Passenger Airlines Market to 2024: Market Segments Sizing and Revenue Analytics provides deep dive data analytics on wide ranging Passenger Airlines market aspects including overall airlines no. of seats sold, load factor, passenger kilometers available etc. all categorized by different service offerings – Low Cost, Full Service and Charter Services. Furthermore, the report details out number of revenue-generating airline passenger kilometers since 2015 to 2024 along with other critical aspects of the Passenger Airlines market. Read More

Unisex Fragrances (Fragrances) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Unisex Fragrances market in Germany. Read More

Energy Bars (Bakery and Cereals) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Energy Bars market in Germany. The research handbook provides up-to-date market size data for period 2014-2019 and illustrative forecast to 2024 premised on Covid-19 hit, covering key market aspects like Sales Value and Volume for Energy Bars and its variants . Read More

Ambient (Canned) Meat (Meat) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Canned Meat market in Germany. The research handbook provides up-to-date market size data for period 2014-2019 and illustrative forecast to 2024 premised on Covid-19 hit,covering key market aspects like Sales Value and Volume for Canned Meat and its variants . Read More

Toothbrushes and Replacement Heads (Oral Hygiene) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Toothbrushes & Replacement Heads market in Germany. Read More

Pretzels (Savory Snacks) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Pretzels market in Germany. The research handbook provides up-to-date market size data for period 2014-2019 and illustrative forecast to 2024 premised on Covid-19 hit,covering key market aspects like Sales Value and Volume for Pretzels and its variants . Read More

Chilled Noodles (Pasta and Noodles) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Chilled Noodles market in Germany. Read More

Dried Fish and Seafood (Fish and Seafood) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Dried Fish & Seafood market in Germany. The research handbook provides up-to-date market size data for period 2014-2019 and illustrative forecast to 2024 premised on Covid-19 hit,covering key market aspects like Sales Value and Volume for Dried Fish & Seafood and its variants . Read More

Germany Government Tax Revenue: Share of Income & VAT data was reported at 6,414.000 EUR mn in Mar 2025. This records an increase from the previous number of 4,301.000 EUR mn for Feb 2025. Germany Government Tax Revenue: Share of Income & VAT data is updated monthly, averaging 3,162.000 EUR mn from Jan 2006 (Median) to Mar 2025, with 231 observations. The data reached an all-time high of 8,649.000 EUR mn in Dec 2024 and a record low of 1,332.400 EUR mn in Mar 2006. Germany Government Tax Revenue: Share of Income & VAT data remains active status in CEIC and is reported by Federal Ministry of Finance. The data is categorized under Global Database’s Germany – Table DE.F005: Government Tax Revenue: Bundesministerium der Finanzen. [COVID-19-IMPACT]

Soymilk and Soy Drinks (Dairy and Soy Food) Market in Germany – Outlook to 2024; Market Size, Growth and Forecast Analytics (updated with COVID-19 Impact) is a broad level market review of Soymilk & Soy Drinks market in Germany. The research handbook provides up-to-date market size data for period 2014-2019 and illustrative forecast to 2024 premised on Covid-19 hit, covering key market aspects like Sales Value and Volume for Soymilk & Soy Drinks and its variants Soy Cream, Soy Drinks, Soymilk Liquid and Soymilk Powdered. Read More

Syntax files to replicate the analyses in the paper "Socio‑economic status, comparisons of subjective affectedness and life satisfaction during the COVID‑19 pandemic in Germany" (https://doi.org/10.1007/s11205-025-03000-1) using the SOECBIAS-COVREF data: Beblo, Miriam, Jäger, Julian, Lohmann, Henning, Sattler-Bublitz, Elisabeth, & Wang, Hequn (2024). SOECBIAS-COVREF Data Set. GESIS, Cologne. Data File Version 2.0.0, https://doi.org/10.7802/2772 as well as NUTS-3 level data on COVID-19 cases and deaths by the Robert Koch Institute (https://www.arcgis.com/home/item.html?id=f10774f1c63e40168479a1feb6c7ca74, last accessed: 13.01.2023) and on short-time work by the Federal Employment Agency (https://statistik.arbeitsagentur.de/SiteGlobals/Forms/Suche/Einzelheftsuche_Formular.html?topic_f=kurzarbeit-endg, last accessed: 05.01.2024).

Abstract: This paper examines the role of social comparisons in evaluating the consequences of the COVID-19 pandemic in Germany between 2020 and 2022. Our approach drew on previous research concerning economic inequalities and reference groups, engaging with the broader literature on comparisons and subjective well-being. We hypothesized that individuals’ evaluations of their personal economic affectedness—what we term “subjective affectedness”—would be influenced not only by objective factors such as employment and income changes but also by their socioeconomic status at the onset of the pandemic. We primarily investigated how individuals evaluate their subjective affectedness in relation to others and how these evaluations varied according to their initial socioeconomic status. Additionally, we analyzed whether these comparisons influenced subjective well-being, specifically life satisfaction, during the pandemic. Our results show that individuals generally viewed themselves as economically less affected than others, including their immediate social circle, other people in Germany, and especially others in the EU. However, lower-status groups perceived both themselves and others as more affected and were more likely to assess themselves as more affected than others—even in the absence of objective factors such as job or income loss. Our findings suggest that individuals rely on personal reference groups, which leads to biased evaluations of others. Those who evaluated themselves as more affected than others also reported lower life satisfaction. Overall, our findings indicate that socioeconomic status played a crucial role in shaping evaluations and social comparisons during the pandemic.

Result data related to "Bersalli et al (2024): Economic crises as critical junctures for policy and structural changes towards decarbonization – the cases of Spain and Germany". The following files are included:

• "Energy policy 2020-21 Germany-Spain.xlsx": Policy measures supporting clean energy during the Covid-19 pandemic in Germany and Spain. Data from EnergyPolicyTracker.org, amended by the authors.
• "factors.csv": Time series of emissions, population, GDP, energy intensity, and carbon intensity. Data derived from BP and Eurostat.
• "multiplicative-contribution-factors.csv": Time series of relative growth in the factors.
• "relative-cumulative-contribution-factors.csv": Time series of cumulative relative growth in the factors.
• "periods.csv": Relative growth in the factors during the global financial and COVID19 crises and before (pre) and after (post) the global financial crisis.

Germany has long been involved with international asylum applications, especially in recent years. The most applications came from Syrian asylum seekers. These was followed by applications from Afghanistan and Turkey. Germany as a refuge choice Statistics on the number of asylum applicants in Germany are recorded by the BAMF, or the Federal Office for Migration and Refugees (Bundesamt für Migration und Flüchtlinge). The coronavirus (COVID-19) pandemic has decreased refugee numbers in Europe, with travel bans across modes of transport and borders being closed. As the restrictions begin to lift, migration is beginning again. 2023 saw the highest number of applications for asylum since 2016. However, in 2024, numbers have decreased significanly again. Support for refugees remains a present issue, fraught with tension, legal complications and surrounded by constant debate with many believing that not enough is done to support them. Asylum decisions Not all asylum applications in Germany get accepted, due to various circumstances. Besides rejection, decisions regarding asylum may involve granting a legal status as a refugee, a grant of subsidiary protection or determining a deportation ban.

Snapshot img

Vaccine Research Market Size 2024-2028

The vaccine research market size is forecast to increase by USD 21.4 billion, at a CAGR of 10.84% between 2023 and 2028.

The market is driven by the high prevalence of infectious diseases worldwide, necessitating the continuous development of new and effective vaccines. The adoption of artificial intelligence (AI) in vaccine research is a significant trend, accelerating the R&D process and enabling the discovery of potential vaccine candidates more efficiently. However, the market faces substantial challenges, including the high cost of vaccine research, development, and manufacturing, which can hinder the entry of new players and limit the market's growth potential. Companies seeking to capitalize on market opportunities must navigate these challenges effectively, focusing on cost reduction strategies and collaborations to share resources and expertise.
Additionally, staying abreast of the latest technological advancements in vaccine research, such as AI and gene editing, can provide a competitive edge in this dynamic market.

What will be the Size of the Vaccine Research Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by the ongoing need for epidemic and pandemic preparedness. This dynamic landscape encompasses various sectors, including cold chain technology, public health, drug discovery, and inactivated vaccines. In this context, continuous research and development efforts are underway to address the challenges of supply chain management, manufacturing processes, and regulatory approval. In the realm of inactivated vaccines, in-vivo studies and in-vitro experiments are integral to understanding their efficacy and safety. Meanwhile, conjugate vaccines and viral vectors are gaining prominence in disease models, offering potential solutions to antigenic shift and drift. Manufacturing processes are being refined through the adoption of needle-free delivery systems and advances in quality control.

Regulatory approval processes are also undergoing transformation, with data analysis playing a crucial role in ensuring vaccine safety and efficacy. Moreover, the market is witnessing the emergence of next-generation sequencing, which is revolutionizing the understanding of disease surveillance and vaccine efficacy trials. The ongoing research in this field is also addressing concerns related to long-term effects, vaccine hesitancy, and variant-specific vaccines. The market's evolution is further influenced by the ongoing development of DNA vaccines, RNA vaccines, and recombinant vaccines, which are undergoing various phases of clinical trials. The importance of animal models and immunization schedules in the context of herd immunity and global health is also being emphasized.

As the market continues to unfold, it is essential to remain attuned to the evolving patterns and applications across various sectors. The ongoing research in this field is critical to addressing the challenges of infectious diseases and ensuring public health.

How is this Vaccine Research Industry segmented?

The vaccine research industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Public
  Private


Age Group

  Pediatric
  Adult


Technology

  Recombinant Vaccines
  mRNA Vaccines
  Subunit Vaccines
  Live-Attenuated Vaccines
  Inactivated Vaccines
  Viral Vector Vaccines
  Conjugate Vaccines
  Toxoid Vaccines
  Adjuvants


Disease Type

  Infectious Diseases
  Cancer
  Autoimmune Diseases
  Allergies
  Neurological Disorders


Research Phase

  Preclinical Research
  Clinical Trials (Phase I, Phase II, Phase III)
  Discovery & Development


End-User

  Pharmaceutical & Biotechnology Companies
  Academic & Research Institutions
  Contract Research Organizations (CROs)
  Government Agencies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    Egypt
    KSA
    Oman
    UAE


  APAC

    China
    India
    Japan


  South America

    Argentina
    Brazil


  Rest of World (ROW)

By End-user Insights

The public segment is estimated to witness significant growth during the forecast period.

In response to the global health crisis caused by the COVID-19 pandemic, governments have significantly invested in vaccine research and development. Institutions like the US National Institute of Allergy and Infectious Diseases (NIAID) and the US National Institutes of Health (NIH) have been at the forefront of this endeavor. The research process involves